Concepedia

Masaru Hayashi

MH

Statistics

Publications

21

Citations

2.5K

H-Index

18

Active since

1999

Affiliations

Shiga University of Medical Science(Current)

Tokai University

University of Southern California

Nagahama City Hospital

Masaru Hayashi is an author at Shiga University of Medical Science specializing in medicine, cardiology, and cardiovascular disease.

Publications per year

1999–2020

21

Publications

21

High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure

Keiko Maeda, Takayoshi Tsutamoto, Atsuyuki Wada et al. · Journal of the American College of Cardiology · 2000 · 419 citations

, , +5

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure

Takayoshi Tsutamoto, Atsuyuki Wada, Keiko Maeda et al. · Journal of the American College of Cardiology · 2001 · 362 citations

, , +14

Immediate Administration of Mineralocorticoid Receptor Antagonist Spironolactone Prevents Post-Infarct Left Ventricular Remodeling Associated With Suppression of a Marker of Myocardial Collagen Synthesis in Patients With First Anterior Acute Myocardial Infarction

Masaru Hayashi, Takayoshi Tsutamoto, Atsuyuki Wada et al. · Circulation · 2003 · 319 citations

, , +15

Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75)

Yasuyoshi Ouchi, Junichi Sasaki, Hidenori Arai et al. · Circulation · 2019 · 223 citations · Full text

, , +17

Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure

Takayoshi Tsutamoto, Atsuyuki Wada, Keiko Maeda et al. · Journal of the American College of Cardiology · 2000 · 196 citations

, , +14

1–5 of 21